45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
9,758
Insurances with rates
21
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| RX-209301 | OCRELIZUMAB 920 MG-HYALURONIDASE-OCSQ 23,000 UNIT/23 ML SUBCUT SOLN|JW DISCARDED DRUG NOT ADMINISTER | $456,434 | $163,404 | — | — | 22 |
| RX-163245 | GLUCARPIDASE 1,000 UNIT INTRAVENOUS SOLUTION | $451,549 | $161,654 | — | — | 16 |
| RX-213646 | PEMBROLIZUMAB 790 MG-BERAHYALURONID-PMPH 9,600 UNIT/4.8 ML SUBCUT SOLN|JW DISCARDED DRUG NOT ADMINIS | $251,255 | $89,949 | — | — | 16 |
| SUP-249.683 | PLATE BONE LC SS 2.7MM 7 HOLE 67MM | $235,370 | $84,262 | — | — | 19 |
| RX-185417 | OCRELIZUMAB 30 MG/ML INTRAVENOUS SOLUTION|JW DISCARDED DRUG NOT ADMINISTERED | $228,217 | $81,702 | — | — | 30 |
| RX-192573 | POLATUZUMAB VEDOTIN-PIIQ 140 MG INTRAVENOUS SOLUTION|JW DISCARDED DRUG NOT ADMINISTERED | $207,342 | $74,229 | — | — | 33 |
| RX-203575 | MOSUNETUZUMAB-AXGB 1 MG/ML INTRAVENOUS SOLUTION|JW DISCARDED DRUG NOT ADMINISTERED | $203,520 | $72,860 | — | — | 30 |
| RX-194405 | TEPROTUMUMAB-TRBW 500 MG INTRAVENOUS SOLUTION|JW DISCARDED DRUG NOT ADMINISTERED | $195,486 | $69,984 | — | — | 22 |
| SUP-222ETCTRSY33 | KIT SPIN CORD STIM ETERNA IPG CONTRL CHRGR | $169,232 | $60,585 | — | — | 12 |
| RX-201068 | NIVOLUMAB 240 MG-RELATLIMAB-RMBW 80 MG/20 ML INTRAVENOUS SOLUTION|JW DISCARDED DRUG NOT ADMINISTERED | $164,252 | $58,802 | — | — | 30 |
| SUP-32400 | GENERATOR PULSE ETERNA IMPLANTABLE 16CH IPG | $153,843 | $55,076 | — | — | 16 |
| RX-141641 | COAGULATION FACTOR VIIA RECOMB 5 MG (5,000 MCG) INTRAVENOUS SOLUTION|JW DISCARDED DRUG NOT ADMINISTE | $151,147 | $54,111 | — | — | 16 |
| SUP-3660 CTRLSYS XX | STIMULATOR SPINAL CORD PROCLAIM ELITE 5 IPG PAT CONTROLLER | $140,732 | $50,382 | — | — | 18 |
| RX-154653 | BRENTUXIMAB VEDOTIN 50 MG INTRAVENOUS SOLUTION|JW DISCARDED DRUG NOT ADMINISTERED | $137,519 | $49,232 | — | — | 33 |
| 548 | SEPTIC ARTHRITIS WITH MCC | $134,932 | $48,306 | — | — | 14 |
| CASE-23472 | Arthroplasty Glenohumeral Joint Total Shoulder | $134,272 | $48,069 | — | — | 16 |
| SUP-3150 | GENERATOR V PULSE INSPIRE IMPLANTABLE RESP SENSING | $131,594 | $47,111 | — | — | 19 |
| RX-193905 | LUSPATERCEPT-AAMT 75 MG SUBCUTANEOUS SOLUTION|JW DISCARDED DRUG NOT ADMINISTERED | $131,421 | $47,049 | — | — | 30 |
| SUP-3664 | GENERATOR PULSE PROCLAIM DRG | $130,680 | $46,783 | — | — | 19 |
| SUP-3662 | GENERATOR PULSE PROCLAIM 7 ELITE | $126,111 | $45,148 | — | — | 19 |
| RX-213645 | PEMBROLIZUMAB 395 MG-BERAHYALURONID-PMPH 4,800 UNIT/2.4 ML SUBCUT SOLN|JW DISCARDED DRUG NOT ADMINIS | $125,628 | $44,975 | — | — | 16 |
| RX-182788 | ATEZOLIZUMAB 1,200 MG/20 ML (60 MG/ML) INTRAVENOUS SOLUTION|JW DISCARDED DRUG NOT ADMINISTERED | $125,458 | $44,914 | — | — | 33 |
| RX-203761 | UBLITUXIMAB-XIIY 25 MG/ML INTRAVENOUS SOLUTION|JW DISCARDED DRUG NOT ADMINISTERED | $123,548 | $44,230 | — | — | 30 |
| SUP-3772 | GENERATOR PRODIGY MRI IPG | $121,237 | $43,403 | — | — | 19 |
| CASE-23430 | Tenodesis Long Tendon Biceps | $118,939 | $42,580 | — | — | 16 |
| SUP-3660 | GENERATOR PULSE PROCLAIM XR 5 | $112,555 | $40,295 | — | — | 19 |
| SUP-3028 | GENERATOR PULSE INSPIRE IMPLABLE | $111,032 | $39,750 | — | — | 19 |
| RX-201832 | RISANKIZUMAB-RZAA 60 MG/ML INTRAVENOUS SOLUTION|JW DISCARDED DRUG NOT ADMINISTERED | $110,527 | $39,569 | — | — | 30 |
| CASE-27447 | Arthrp Kne Condyle&Platu Medial&Lat Compartments | $105,899 | $37,912 | — | — | 16 |
| RX-174175 | VEDOLIZUMAB 300 MG INTRAVENOUS SOLUTION|JW DISCARDED DRUG NOT ADMINISTERED | $105,552 | $37,788 | — | — | 30 |
| CASE-27130 | Arthrp Acetblr/Prox Fem Prostc Agrft/Algrft | $102,341 | $36,638 | — | — | 16 |
| RX-172383 | OBINUTUZUMAB 1,000 MG/40 ML INTRAVENOUS SOLUTION|JW DISCARDED DRUG NOT ADMINISTERED | $99,323 | $35,558 | — | — | 30 |
| SUP-11060A23 | CONDUIT AORTIC VALVED KONECT RESILIA 23MM | $97,477 | $34,897 | — | — | 12 |
| SUP-11060A25 | CONDUIT AORTIC VALVED KONECT RESILIA 25MM | $97,477 | $34,897 | — | — | 12 |
| RX-152479 | IPILIMUMAB 50 MG/10 ML (5 MG/ML) INTRAVENOUS SOLUTION|JW DISCARDED DRUG NOT ADMINISTERED | $96,438 | $34,525 | — | — | 33 |
| RX-9002 | ALTEPLASE 100 MG INTRAVENOUS SOLUTION|JW DISCARDED DRUG NOT ADMINISTERED | $89,255 | $31,953 | — | — | 33 |
| RX-195607 | LURBINECTEDIN 4 MG INTRAVENOUS SOLUTION|JW DISCARDED DRUG NOT ADMINISTERED | $87,815 | $31,438 | — | — | 33 |
| SUP-15-8020/12 | PROSTHESIS KNEE ROT ENDOMODEL ANTILUX DEV LFT XS 17MM | $87,166 | $31,206 | — | — | 19 |
| RX-188486 | NIVOLUMAB 240 MG/24 ML INTRAVENOUS SOLUTION|JW DISCARDED DRUG NOT ADMINISTERED | $84,598 | $30,286 | — | — | 33 |
| RX-601800 | TENECTEPLASE 50 MG INTRAVENOUS SOLN FOR MI OR PE|JW DISCARDED DRUG NOT ADMINISTERED | $82,844 | $29,658 | — | — | 22 |
| RX-191920 | ATEZOLIZUMAB 840 MG/14 ML (60 MG/ML) INTRAVENOUS SOLUTION|JW DISCARDED DRUG NOT ADMINISTERED | $81,966 | $29,344 | — | — | 33 |
| RX-601799 | TENECTEPLASE 25 MG INTRAVENOUS SOLUTION FOR ACUTE ISCHEMIC STROKE (AI)|JW DISCARDED DRUG NOT ADMINIS | $81,835 | $29,297 | — | — | 22 |
| SUP-33680031 | DOME ANKLE FLATCUT TALAR INFINITY ADAPTIS SZ 1 | $79,407 | $28,428 | — | — | 19 |
| RX-186573 | RITUXIMAB 1,600 MG/13.4 ML (120 MG/ML)-HYALURONIDASE SUBCUTANEOUS SOLN|JW DISCARDED DRUG NOT ADMINIS | $78,994 | $28,280 | — | — | 30 |
| SUP-1212.0111S | SPACER SPINAL HEDRON IA 8DEG 24 X 30 X 11MM | $76,763 | $27,481 | — | — | 16 |
| SUP-1212.0213S | SPACER SPINAL HEDRON IA 15DEG 24 X 30 X 13MM | $76,763 | $27,481 | — | — | 16 |
| SUP-33680001 | TRAY TIBIAL INFINITY ADAPTIS STD SZ 1 | $74,844 | $26,794 | — | — | 19 |
| SUP-33680004 | TIBIAL INFINITY ADAPTIS SZ 4 | $74,844 | $26,794 | — | — | 19 |
| SUP-4101 | NEUROSTIMULATOR SACRAL NEUROMOD RECHARGEABLE F15 | $74,021 | $26,500 | — | — | 16 |
| RX-186494 | RITUXIMAB 1,400 MG/11.7 ML (120 MG/ML)-HYALURONIDASE SUBCUTANEOUS SOLN|JW DISCARDED DRUG NOT ADMINIS | $69,120 | $24,745 | — | — | 30 |
Showing top 50 of 9,758 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.